BNTC - CIK 0001808898
Benitec Biopharma Inc. has filed 309 documents with the SEC between 2020 and 2026. The most frequent type is major company event (73 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2026-05-14 | 2026-03-31 |
| Major company event | 8-K | 2026-05-14 | 2026-05-14 |
| Annual report (amended) | 10-K/A | 2026-03-20 | 2025-06-30 |
| Major company event | 8-K | 2026-02-12 | 2026-02-12 |
| Quarterly report | 10-Q | 2026-02-12 | 2025-12-31 |
| 424B3 | - | 2026-02-11 | - |
| EFFECT | - | 2026-02-10 | - |
| Company correspondence | CORRESP | 2026-02-06 | - |
| SEC correspondence | UPLOAD | 2026-02-06 | - |
| Securities registration | S-3 | 2026-01-30 | - |
| Insider trade | 4 | 2026-01-26 | 2026-01-22 |
| Insider trade | 4 | 2025-12-29 | 2025-12-23 |
| Insider trade | 4 | 2025-12-22 | 2025-12-18 |
| SCHEDULE 13G/A | - | 2025-12-08 | - |
| SCHEDULE 13G | - | 2025-12-03 | - |
| Insider trade | 4 | 2025-12-03 | 2025-12-01 |
| Insider trade | 4 | 2025-12-03 | 2025-12-01 |
| Insider trade | 4 | 2025-12-03 | 2025-12-01 |
| Insider trade | 4 | 2025-12-03 | 2025-12-01 |
| Insider trade | 4 | 2025-12-03 | 2025-12-01 |
| Major company event | 8-K | 2025-12-02 | 2025-12-01 |
| Insider trade | 4 | 2025-11-20 | 2025-11-18 |
| Insider trade | 4 | 2025-11-20 | 2025-11-18 |
| Insider trade | 4 | 2025-11-20 | 2025-11-18 |
| Major company event | 8-K | 2025-11-14 | 2025-11-14 |
| Quarterly report | 10-Q | 2025-11-14 | 2025-09-30 |
| Proxy materials | DEFA14A | 2025-11-12 | - |
| SCHEDULE 13D/A | - | 2025-11-10 | - |
| Insider trade | 4 | 2025-11-10 | 2025-11-07 |
| Major company event | 8-K | 2025-11-07 | 2025-11-05 |
| Prospectus supplement | 424B5 | 2025-11-07 | - |
| Insider trade | 4 | 2025-11-07 | 2025-11-05 |
| New insider ownership | 3 | 2025-11-07 | 2025-11-03 |
| Prospectus supplement | 424B5 | 2025-11-05 | - |
| Major company event | 8-K | 2025-11-03 | 2025-11-02 |
| Proxy materials | DEFA14A | 2025-10-14 | - |
| Proxy statement | DEF 14A | 2025-10-14 | 2025-12-01 |
| EFFECT | - | 2025-09-29 | - |
| Company correspondence | CORRESP | 2025-09-26 | - |
| SEC correspondence | UPLOAD | 2025-09-25 | - |
| Securities registration | S-3 | 2025-09-22 | - |
| Major company event | 8-K | 2025-09-22 | 2025-09-22 |
| Annual report | 10-K | 2025-09-22 | 2025-06-30 |
| Major company event | 8-K | 2025-09-12 | 2025-09-10 |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| Major company event | 8-K | 2025-07-09 | 2025-07-09 |
| EFFECT | - | 2025-06-02 | - |
| 424B3 | - | 2025-06-02 | - |
| Company correspondence | CORRESP | 2025-05-29 | - |